Registration Form – Deadline 0ctober 6th 2011--

Preliminary Program
6th Meeting of the Immunotherapy Network IMMUNONET
NEW TRENDS IN IMMUNOTHERAPY SYMPOSIUM
November 7th 2011
Hotel Mercure Montpellier Centre, Montpellier, France
9:00 Reception and registration
9:30 Welcome speech
KEYNOTE LECTURE:
10:00-10:45 Pere Santamaria, Director of the Julia McFarlane Diabetes Research Centre,
Canada.
“Harnessing autoregulatory T-cell memory for the treatment of autoimmune
disease”.
10:45-11:00 Coffee break
EDUCATIONAL SESSION: Novel strategies for immune intervention.
- Therapy of Immunodeficiency diseases
11:00-11:30 Naomi Taylor, IGMM, CNRS, Montpellier, France.
- Immunotherapy of cancer
11:30-12:00 Luis Álvarez-Vallina. Fundación de Investigación Biomédica. Unidad de
Inmunología Molecular. Hospital Universitario Puerta de Hierro- Majadahonda.
Madrid. Spain.
“In vivo selection of human antibodies in tumor bearing mice”
- Immunotherapy of Rheumatoid Arthritis
12:00-12:30 Jean-Luc Davignon, Institut National de la Santé et de la Recherche Médicale
(INSERM). Toulouse. France
“A phosphorus-based dendrimer targets inflammation and osteoclastogenesis
in experimental arthritis”.
12:30-13:30 Lunch

SESSION I: Autoimmunity
13:30-14:00 Abdelhadi Saoudi, Institut National de la Santé et de la Recherche Médicale
(INSERM). Toulouse. France
“VAVI gene variants in CNS autoimmunity”.
14:40-14:20 Javier Hernández. Institut de Génétique Moléculaire de Montpellier,
IGMM, CNRS, Montpellier. France.
“Lymphopenia and the breakdown of peripheral T cell tolerance”.
14:20-14:40 Lennart Mars. Institut National de la Santé et de la Recherche Médicale
(INSERM). Toulouse. France
“Myelin-specific T cells that co-recognise a neuronal autoantigen
drive chronic inflammation in an animal model of Multiple Sclerosis”.
14:40-15:00 Talks selected from abstracts.
SESSION II Immunotherapy of cancer
15:00-15:20 Pedro Berraondo. Laboratorio de Inmunología del Centro de Investigación
Médica Aplicada (CIMA) de la Universidad de Navarra. Pamplona. Spain.
“Cytokine fusion proteins with Apolipoprotein AI”
15:20-15:40 Carlos Cuesta. Fundación de Investigación Biomédica. Servicio de
Inmunología. Hospital Universitario de la Princesa. Madrid. Spain.
“The blockage of the CCR7-cortactin pathway with anti-CCR7 immunotherapy
may prevent breast cancer invasion and metastasis”.
15:40-16:00 Talks selected from abstracts.
16:00-16:20 Coffee break
SESSION II Immunotherapy of Inflammatory diseases
16:20-16:50 Florence Apparailly. Institut National de la Santé et de la Recherche Médicale
(INSERM U844), Montpellier, France.
“In vivo targeting of inflammatory monocytes for efficient RNAi-mediated
immuno-intervention in autoimmune diseases”.
16:50-17:10 Luis Graça. Instituto de Medicina molecular (IMM). Lisboa. Portugal.
“Regulation of germinal center reaction and antibody production”
17:10-17:30 África González-Fernández. Centro de Investigaciones Biomédicas
(CINBIO). Universidad de Vigo. Spain
“Alternative routes of immunization using nanovaccines”.

17:30-17:50 Elva Bonifacio Andrade. Instituto de Ciências Biomédicas de Abel
Salazar - Universidade do Porto (ICBAS-UP). Porto. Portugal.
“TLR2 as a prospective target for immunotherapy of Streptococcus
agalactiae”.
17:50-18:10 Talks selected from abstracts.
CONCLUDING REMARKS
18:10-18:20 África González-Fernández. IMMUNONET coordinator.
PRIVATE SESSION:
18:30 IMMUNONET Steering committee meeting